Aprocitentan

Short Description:

API’s Name CAS No. US DMF Patent Expiry Date (US) Current Status
Aprocitentan  1103522-45-7  Dec, 2026  Sep.21, 2034 estimated PV Completion – Oct, 2026

 

[Indication] 

  • For the treatment of hypertension, in combination with other antihypertensive agents.


Product Detail

Product Tags


  • Previous:
  • Next:

  • Write your message here and send it to us